Abstract
Severe Malaria and Artesunate Treatment, Norway
Highlights
With the exception of 1 patient who had become infected while in Myanmar, all patients acquired falciparum malaria in West Africa (Table)
In the United States, artesunate for infusion may be obtained as an investigational drug from the Centers for Disease Control and Prevention, and in the European Union, artesunate recently received the Orphan Medicinal Drug Designation from the European Medicines Agency and may be obtained from IDIS Pharma
If falciparum malaria is acquired at the Cambodia–Thailand border region, artesunate resistance should be considered; except for this region, where mefloquine resistance is a problem, artesunate is considered to be an efficacious drug with limited reports of resistance
Summary
With the exception of 1 patient who had become infected while in Myanmar, all patients acquired falciparum malaria in West Africa (Table). A major obstacle for the use of IV artesunate is its poor availability outside Asia and the fact that its use is not approved in many countries. In the United States, artesunate for infusion may be obtained as an investigational drug from the Centers for Disease Control and Prevention
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
